StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
3048
This month
62
This week
15
This year
230
Today
10
Yesterday
13
Publishing Date
2024 - 04 - 24
10
2024 - 04 - 23
3
2024 - 04 - 22
2
Sector
Finance and insurance
1
Health technology
8
Manufacturing
5
N/a
1
Professional, scientific, and technical services
1
Tags
Acquisition
9
Agreement
20
Approval
9
Asco
9
Award
10
Biopharma
9
Business
14
Cancer
15
Cell
18
Ceo
14
Collaboration
11
Company
27
Conference
70
Corporation
38
Day
14
Development
13
Drug
12
Earnings
15
Energy
30
Fda
13
Financial
140
First
240
For
199
Global
26
Group
35
Growth
21
Health
11
International
11
Key
37
Life
13
Management
9
Market
79
Medical
11
Meeting
35
Million
40
N/a
989
Nasdaq
19
Offering
17
One
12
Partnership
13
Pharmaceuticals
19
Platform
12
Positive
15
Presentation
18
Program
17
Reach
24
Report
90
Research
26
Results
211
Revenue
11
Set
38
Solutions
20
Study
18
Technology
21
Therapeutics
42
Therapy
20
Treatment
26
Trial
17
Update
19
Year
20
Entities
Altamira therapeutics ltd
1
Aslan pharmaceuticals limited
1
Calliditas therapeutics ab
1
Capricor therapeutics, inc.
1
Corcept therapeutics incorporated
1
Envveno medical corporation
2
Gain therapeutics inc
1
Immutep limited
1
Innoviva, inc.
1
La jolla pharmaceutical company
1
Neurocrine biosciences, inc.
1
Novartis ag
1
Silo pharma, inc.
1
Stellantis n.v
1
Takeda pharmaceutical company limited
1
Theriva biologics inc
1
Symbols
ASLN
1
CALT
1
CAPR
1
CORT
1
CYTO
1
GANX
1
IMMP
1
INVA
1
LJPC
1
NBIX
1
NVNO
2
NVS
1
NVSEF
1
SILO
1
SILOD
1
STLA
1
TAK
1
TOVX
1
Exchanges
Nasdaq
13
Nyse
4
Crawled Date
2024 - 04 - 24
10
2024 - 04 - 23
3
2024 - 04 - 22
2
Crawled Time
05:00
1
08:00
1
11:00
3
12:00
5
13:00
4
13:30
1
Source
www.biospace.com
3
www.globenewswire.com
9
www.hancockjaffe.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This week
tags :
Positive
save search
Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy
Published:
2024-04-24
(Crawled : 13:00)
- globenewswire.com
CAPR
|
$5.19
7.68%
600K
|
Health Technology
|
0.0%
|
O:
7.88%
H:
0.0%
C:
0.0%
cap-1002
fda
positive
program
therapeutics
duchenne
type-b meeting
Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for GBA1 Parkinson’s Disease
Published:
2024-04-24
(Crawled : 13:00)
- globenewswire.com
GANX
|
$3.31
-2.36%
100K
|
Professional, Scientific, and T...
|
0.0%
|
O:
-0.29%
H:
0.0%
C:
0.0%
gt-0228
disease
positive
for
parkinson’s
trial
therapeutics
therapy
results
Altamira Therapeutics Announces Publication of Positive Results from Bentrio Trial in Seasonal Allergic Rhinitis in Top Peer Reviewed Journal
Published:
2024-04-24
(Crawled : 13:00)
- globenewswire.com
CYTO
|
$1.485
-6.01%
2.8M
|
Manufacturing
|
0.0%
|
O:
-0.63%
H:
0.0%
C:
0.0%
positive
publication
bentrio
trial
therapeutics
results
Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
Published:
2024-04-24
(Crawled : 12:00)
- globenewswire.com
IMMP
|
$2.9
15.54%
460K
|
Health Technology
|
3.29%
|
O:
14.4%
H:
0.0%
C:
0.0%
tacti-003
positive
topline
results
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
Published:
2024-04-24
(Crawled : 12:00)
- biospace.com/
NVNO
|
$5.17
-6.0%
52K
|
Manufacturing
|
7.84%
|
O:
8.82%
H:
0.0%
C:
0.0%
symposium
positive
topline
trial
today
Innoviva Specialty Therapeutics’ Positive Phase 3 Oral Zoliflodacin Data for the Treatment of Uncomplicated Gonorrhea Announced at ESCMID Global 2024
Published:
2024-04-24
(Crawled : 12:00)
- biospace.com/
INVA
|
$15.21
0.26%
47K
|
Health Technology
|
0.97%
|
O:
0.77%
H:
0.0%
C:
0.0%
positive
treatment
global
for
Argentina Lithium Announces Positive Lithium Values in the 12th Exploration Well at the Rincon West Project
Published:
2024-04-24
(Crawled : 11:00)
- prnewswire.com
STLA
|
$24.845
-0.46%
2M
|
Manufacturing
|
0.36%
|
O:
0.3%
H:
0.0%
C:
0.0%
west
lithium
positive
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical’s VenoValve® Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
Published:
2024-04-24
(Crawled : 11:00)
- hancockjaffe.com
NVNO
|
$5.17
-6.0%
52K
|
Manufacturing
|
7.84%
|
O:
8.82%
H:
0.0%
C:
0.0%
venovalve
symposium
positive
topline
trial
today
Calliditas Announces Positive NefIgArd Open Label Extension Results
Published:
2024-04-24
(Crawled : 08:00)
- prnewswire.com
CALT
|
$18.2
540
|
Health Technology
|
0.0%
|
O:
1.65%
H:
0.0%
C:
0.0%
label
positive
nefigard
extension
results
Novartis and Medicines for Malaria Venture announce positive efficacy and safety data for a novel treatment for babies <5 kg with malaria
Published:
2024-04-24
(Crawled : 05:00)
- globenewswire.com
NVS
|
News
|
$97.515
0.24%
820K
|
Health Technology
|
0.0%
|
O:
-0.49%
H:
0.0%
C:
0.0%
malaria
positive
treatment
for
novartis
Neurocrine Biosciences Reports Positive Phase 2 Data for NBI-1065845 in Adults with Major Depressive Disorder
Published:
2024-04-23
(Crawled : 13:30)
- biospace.com/
TAK
|
News
|
$13.23
-1.12%
300K
|
Health Technology
|
-0.11%
|
O:
-0.11%
H:
0.0%
C:
0.0%
NBIX
|
News
M
|
$139.34
-0.53%
230K
|
Health Technology
|
4.81%
|
O:
5.49%
H:
2.84%
C:
-0.65%
nbi-1065
positive
for
Silo Pharma Announces Positive Results for Intranasal PTSD Treatment
Published:
2024-04-23
(Crawled : 12:00)
- globenewswire.com
SILO
|
$1.78
170K
|
Finance and Insurance
|
-9.18%
|
O:
9.18%
H:
0.47%
C:
-16.82%
pharma
positive
treatment
for
results
Theriva™ Biologics Announces Positive Topline Data from Investigator Sponsored Phase 1 Trial of Intravitreal VCN-01 in Pediatric Patients with Refractory Retinoblastoma
Published:
2024-04-23
(Crawled : 11:00)
- globenewswire.com
TOVX
|
News
|
$0.362
-3.95%
63K
|
Manufacturing
|
-7.32%
|
O:
2.44%
H:
0.0%
C:
-9.52%
vcn-01
positive
topline
trial
ASLAN Pharmaceuticals Announces Positive Interim Results From Phase 2 Study of Eblasakimab in Dupilumab-Experienced Atopic Dermatitis Patients
Published:
2024-04-22
(Crawled : 13:00)
- globenewswire.com
ASLN
|
News
|
$0.4685
-0.11%
300K
|
Health Technology
|
-7.84%
|
O:
13.73%
H:
5.17%
C:
-20.69%
dermatitis
positive
pharmaceuticals
results
study
Corcept Announces Positive Results From Open-Label Portion of Pivotal Phase 3 GRACE Trial in Patients With Cushing’s Syndrome
Published:
2024-04-22
(Crawled : 12:00)
- globenewswire.com
CORT
|
News
|
$22.35
-2.83%
280K
|
Health Technology
|
0.48%
|
O:
-6.86%
H:
6.89%
C:
4.6%
positive
trial
results
Gainers vs Losers
57%
43%
Top 10 Gainers
CSSE
4
|
$0.3686
142.02%
76M
|
Consumer Services
CZOO
|
$11.685
134.17%
7.6M
|
BOF
|
$2.05
75.21%
78M
|
AMST
|
$3.14
57.0%
59M
|
Technology Services
LICN
|
$0.7885
40.8%
11M
|
TROO
|
$1.51
38.53%
5.6M
|
Manufacturing
MULN
|
News
|
$3.7
35.53%
6.4M
|
Information
WHLM
|
$6.61
30.12%
400K
|
Commercial Services
RILY
|
$27.91
28.5%
8.9M
|
Finance
RBBN
4
|
$3.25
26.46%
1.5M
|
Electronic Technology
Your saved searches
Save your searches and get alerts when important news are released.